Duloxetine in the treatment of generalized anxiety disorder

  title={Duloxetine in the treatment of generalized anxiety disorder},
  author={Trevor R. Norman and James S Olver},
  journal={Neuropsychiatric Disease and Treatment},
  pages={1169 - 1180}
Duloxetine, a medication with effects on both serotonin and noradrenaline transporter molecules, has recently been approved for the treatment of generalized anxiety disorder. The evidence for its efficacy lies in a limited number of double blind, placebo controlled comparisons. Statistically significant improvements in the Hamilton Anxiety Rating Scale from baseline were demonstrated in all studies at doses of 60 to 120 mg per day. The significance of such changes in terms of clinical… CONTINUE READING
0 Citations
58 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 58 references

Improvements of psychic and somatic symptoms in adult patients with genearalised anxiety disorder: examination froma a duloxetine, venlafaxine extended release and placebo trial

  • H Nicolini, D Bakish, H Duenas
  • Psychol Med,
  • 2008
Highly Influential
3 Excerpts

Cognitive behavioural and pharmacological treatment of generalised anxiety disorder: a preliminary meta-analysis

  • RA Gould, MW Otto, MH Pollack
  • Behav Res Ther,
  • 1997
Highly Influential
1 Excerpt

Similar Papers

Loading similar papers…